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Decreased expression but increased activity of PDK1 has been observed in
neurodegenerative disease. To study in vivo function of PDK1 in neuron survival during
cortical development, we generate forebrain-specific PDK1 conditional knockout (cKO)
mice. We demonstrate that PDK1 cKO mice display striking neuron loss and increased
apoptosis. We report that PDK1 cKO mice exhibit deficits on several behavioral tasks.
Moreover, PDK1 cKO mice show decreased activities for Akt and mTOR. These results
highlight an essential role of endogenous PDK1 in the maintenance of neuronal survival
during cortical development.
Keywords: PDK1, Akt, mTOR, neuron loss, apoptosis, learning and memory
INTRODUCTION
PDK1, a kinase in the PI3K signaling pathway, plays pivotal roles in various biological
processes such as cell growth, longevity, and metabolism (Engelman et al., 2006). Activated
PI3K phosphorylates phosphatidylinositol bisphosphate (PIP2) to generate phosphatidylinositol
trisphosphate (PIP3). PDK1 is recruited to the intracellular membrane by PIP3 via its PH domain
and then phosphorylates Akt at the 308 threonine (Thr) residue (Alessi et al., 1997; Calleja et al.,
2007). On the other hand, the lipid phosphatase PTEN deactivates PDK1 by transforming PIP3 to
PIP2 (Engelman et al., 2006). AGC kinase members such as p90 ribosomal S6 kinase 1/2 (RSK1/2),
p70 ribosomal S6 kinase (p70S6K), serum- and glucocorticoid-induced protein kinase (SGK), and
protein kinase C (PKC) are substrates for PDK1 (Mora et al., 2004; Kharebava et al., 2008).
Due to embryonic lethal effect caused by PDK1 knockout in the whole body, it has been
impossible to use PDK1−/− mice to study in vivo functions of PDK1 in the postnatal cerebral
cortex. The advantage of viable cell-type specific PDK1 conditional knockout (cKO) mice has
helped solve this problem. Recent work showed that conditional deletion of PDK1 through GFAP-
Cre mediated gene recombination causes microcephaly in mice, indicating a critical role of PDK1
in brain development (Chalhoub et al., 2009). A conditional knock-in mouse model expressing the
PDK1 L155E mutation displays microcephaly as well (Cordon-Barris et al., 2016). In addition, it
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has been demonstrated that PDK1 in neural progenitor cells
(NPCs) is important for the generation of oligodendrocyte
precursor cells (Watatani et al., 2012) and neuronal migration
(Itoh et al., 2016). The work on epidermis-specific PDK1 cKO
mice has revealed an essential role of PDK1 in asymmetric cell
division (Dainichi et al., 2016).
Recent evidence has shown that PDK1 is involved in
neurodegenerative disease, but how it exerts its role is
controversial. On one hand, reduced PDK1 levels (Liu et al., 2011)
and impaired PI3K signaling (Steen et al., 2005; Talbot et al.,
2012) were found in Alzheimer’s disease (AD) brain, suggesting
a loss-of-function manner. On the other hand, another group
reported that PDK1 activity was increased in AD brain, and
that PDK1 inhibitor enhanced α-secretase activity and reduced
amyloid plaques in APP transgenic (Tg) mouse models of AD
(Pietri et al., 2013), suggesting a gain-of-function mechanism.
Kharebava et al. (2008) have recently demonstrated that
over-expression of PDK1 reduces trophic deprivation (TD)-
induced apoptosis, and that RSK1/2 is required for PDK1-
mediated neuroprotection. However, it remained uninvestigated
whether endogenous PDK1 plays a critical role in neuronal
survival during cortical development. We aimed to address
this question in the present study. Here, we have crossed
PDK1f /f mice with a forebrain neuron-specific Cre Tg line
(Gorski et al., 2002) to generate PDK1 cKO (PDK1f /f ;Emx1-
Cre) animals, in which PDK1 is inactivated in excitatory neurons
of the cortex. We show that PDK1 levels were significantly
reduced in the cortex of PDK1 mutant mice. We report
that PDK1 cKO mice display striking neuron loss, abnormal
apoptosis, and severe memory deficit. We find that PDK1 cKO
mice exhibit decreased Akt/mTOR activities. These findings
highlight a protective role of endogenous PDK1 during brain
development.
MATERIALS AND METHODS
Animal Care and Use
PDK1 cKO mice were generated by crossing floxed PDK1f /f mice
(Feng et al., 2010) with Emx1-Cre Tg (Gorski et al., 2002). Emx1-
Cre and mTmG mice (Muzumdar et al., 2007) were purchased
from the Jackson Laboratory (Bar Harbor, ME, United States).
To generate PDK1 cKO mice, we crossed homozygous PDK1f /f
with Emx1-Cre to obtain PDK1f /+;Emx1-Cre mice, which were
then bred with PDK1f /f to get PDK1f /f ;Emx1-Cre (PDK1
cKO). PDK1f /+;Emx1-Cre mice grow normally and their brain
morphology did not differ from that of PDK1f /+ or PDK1f /f mice
in our analyses. Therefore, PDK1f /+;Emx1-Cre and PDK1f /f
served as littermate controls to PDK1 cKOs. To detect the floxed
PDK1 allele, the following primers were used. The forward primer
is TGTGCTTGGTGGATATTGAT and the reverse primer is
AAGGAGGAGAGGAGGAATGT.
The mice were kept on 7:00AM–19:00PM light cycle under
conditions of constant humidity and temperature (25 ± 1◦C).
The mice were group-housed (4–5 per cage) throughout the
experimental period and had ad libitum access to food and
water. Both male and female mice were used in this study.
Behavioral experiments were conducted during the light phase
of the cycle (8:00AM–18:00PM). Different cohorts of mice were
used for behavioral and biochemical experiments. The mice were
bred and maintained in an SPF level of animal room in the
core facility of the Model Animal Research Center (MARC) at
Nanjing University. The genetic background of the mice used in
this study was C57BL/6. Mouse breeding was conducted under
IACUC approved protocols at the MARC. All the experiments
were performed in accordance with the Guide for the Care
and Use of Laboratory Animals of the MARC at Nanjing
University.
Brain Lysate Preparation
Mice were euthanized by CO2 at 3 weeks or 3 months of
age. Tissues from various brain areas were quickly collected
and then placed into liquid nitrogen. Cortical samples were
homogenized in cold RIPA (radio immunoprecipitation assay)
lysis buffer [consisting of the following (in mM): 20 mM
Tris–HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% NP-40,
0.5% sodium deoxycholate, and 0.1% SDS] containing protease
and phosphatase inhibitors (Thermo). Lysates were cleared by
centrifugation (14,000 rpm for 15 min). Samples were stored at
−80◦C until use. Protein concentration was analyzed using a
standard BSA method.
Western Blotting
Normalized cortical samples (40 µg total protein) were
used in 12% SDS–PAGE (Invitrogen) and then transferred
to nitrocellulose membrane. After blocking with 5% (w/v)
dry milk for 1 h, membranes were incubated with primary
antibodies overnight and reacted with infrared dye-coupled
secondary antibodies (goat anti-rabbit IRdye800, goat anti-
rabbit IRdye680, goat anti-mouse IRdye800, or goat anti-
mouse IRdye680). Membranes were scanned using the Odyssey
Infrared Imaging System (Li-Cor). The following antibodies were
purchased from the CST: total-Akt (1:1000), pAktS473 (1:600),
GSK3α/3β (1:1000), pGSK3αS21/3βS9 (1:600), pAktT308 (1:500),
pAkt substrates (1:500), pPKA substrates (1:500), pCREBSer133
(1:400), pS6KThr389 (1:1000), S6K (1:1000), pS6Ser235/236 (1:1000),
and S6 (1:1000). The following antibodies were also used: anti-
PDK1 (1:1000, Thermo), PKA Reg1α (1:1000, Santa Cruz),
NeuN (1:500, Millipore), β-actin (1:10000, Sigma–Aldrich), and
GAPDH (1:10000, Genetex).
Paraffin Brain Blocks and Nissl Staining
The mouse at 3 weeks or 3 months was placed into a CO2 box
for about 10 s so that its respiration became quite faint and its
heartbeat got weak. Immediately after the CO2 treatment, cardiac
perfusion was conducted using 15 ml 4% paraformaldehyde
(PFA) solution (in phosphate buffer saline, PBS) in a well-
ventilated hood. The brain was dissected out and then fixed
in PFA overnight. After fixation, the brain was dehydrated and
embedded in paraffin.
After embedding, several paraffin brain blocks were prepared.
In each block, 4 hemi-brains, including 2 controls and 2 cKOs,
were placed together and were sectioned sagittally (10 µm)
using a microtome (Leica Microsystems, Bannockburn, IL,
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United States). This way allowed 4 brain sections (2 from the
control and 2 from the cKO group), which were on identical
stereotaxic plane, to be placed on the same slide. For embryos,
the head was fixed in 4% PFA overnight and was later embedded
in paraffin. Coronal brain sections for each embryo were collected
individually.
Sections were incubated at 58◦C for 1 h, deparaffinized in
xylene and re-hydrated. They were rinsed in PBS for 5 min,
soaked in 0.5% cresyl violet for 12 min, and then dehydrated
by a series of ethanol (70, 90, 95, and 100%). After the sections
were cleared in xylene, they were coverslipped with neutral resin
(Sinopharm Chemical Reagent Co., Ltd., Shanghai).
The Cortex Volume, Neuron Counting,
and Cell Density
A method described by us previously (Tabuchi et al., 2009; Chen
et al., 2010) was used to measure the cortex volume and to
count the total number of neurons. It was based on an unbiased
stereological neuron counting technique (West and Gundersen,
1990).
The following experiments were conducted to measure the
cortex volume for each hemi-brain. First, for each paraffin block,
a total of 8 brain slides spaced 400 µm apart were selected for
Nissl staining. Since each paraffin block contained 2 control and
2 cKO hemi-brains, there were 4 brain sections on each slide. The
section thickness was 10 µm. Second, Nissl-stained images were
captured and the area for the cortex in each brain section was
measured using the Olympus CellSens Standard system. For each
mouse, areas for the cortex from 8 (control) or 6 (cKO) sections
were averaged to obtain the mean value across sections. Third,
the volume of a hemi-cortex was calculated using the following
formula: volume = the mean area × the total thickness of a
hemi-brain. The latter was 3200 µm for control but 2400 µm for
cKO.
The following experiments were performed to calculate the
total number of cortical NeuN+ cells for each hemi-brain.
First, NeuN immunohistochemistry (IHC) was conducted using
8 slides spaced 400 µm apart from each paraffin brain block.
Second, for each NeuN-stained section, a total of 10 microscopic
fields were randomly selected under the 40× magnification lens
of an Olympus BX53 microscope. Each microscopic field was
100 µm× 100 µm× 10 µm (105 µm3) in size and was defined as
a counting unit. Third, the total number of NeuN+ cells in each
counting unit was counted. The numbers were then averaged
across sections to obtain a mean value for NeuN+ cell number
per unit. The cell density was defined as the number of NeuN+
cells in a 1 mm3 area. It was calculated using the following
formula: density = mean number of NeuN+ cell/mm3. Fourth,
the total number of cortical NeuN+ cells in each hemi-brain
was calculated using the following formula: total number = cell
density× the cortex volume.
For the measurement of the diameter of cell bodies of NeuN+
cells, a total of 345 cells in the NeuN-stained images for PDK1
cKO at 3 weeks and 365 cells in PDK1 cKO at 3 months
were randomly selected to calculate the averaged value (n = 3
mice/group/age).
BrdU Labeling
BrdU (B5002, Sigma–Aldrich) was administered to pregnant
dams at the concentration of 100 mg/kg. To label proliferating
NPCs, BrdU was intraperitoneally injected to pregnant dams
at E13.5, E15.5, and E17.5. Embryonic brains were collected
30 min after the injection and were then processed for paraffin
embedding. Each paraffin block contained only one embryonic
brain, and serial coronal sections were prepared using a
microtome.
Immunohistochemistry and Cell
Counting
Brain sections were immunostained with antibodies against
NeuN (1:500, Millipore), PDK1 (1:1000, Abcam), SVP38
(1:500, Millipore), microtubule-associated protein 2 (MAP2)
(1:500, Millipore), BrdU (1:500, Abcam), PH3 (1:500, CST),
GFAP (1:500, Sigma–Aldrich), and Iba1 (1:500, Wako). For
fluorescence IHC (FIHC), sections were incubated with
Alexa Fluor 488 secondary antibodies (Invitrogen, 1:500) or
Cy3/Cy5 secondary antibodies (Jackson ImmunoResearch;
1:500). Immunofluorescence images were captured using a
Leica TCS SP5 laser confocal microscope except for MAP2
staining.
For BrdU+ cell counting, three coronal sections spaced
200 µm apart from each embryo were used. Images for cortical
BrdU staining were captured under the 40× objective lens of
a Leica confocal laser scanning microscope. In each image, 2
counting units were randomly selected and each unit was an
area of 100 µm (surface of the ventricular zone, VZ) × 200 µm
(vertical to the VZ surface). The total number of BrdU+ cells in
each unit was counted. For each embryo, the number of BrdU+
cells was averaged across 6 counting units to make the mean
number.
For PH3+ cell counting, three coronal sections spaced 200µm
apart from each embryo were used. Images were captured
under the 10× objective lens of a Leica confocal laser scanning
microscope. The total number of PH3+ cells on the surface
of VZ was counted. The number was then averaged across 3
sections to obtain the mean number of PH3+ cells for each
embryo.
TUNEL Staining
Brain sections were blocked with 5% goat serum for 30 min and
then treated with the TUNEL (terminal deoxynucleotidyl
transferase-mediated dUTP-biotin nick end-labeling)
BrightGreen Apoptosis Detection Kit (Vazyme) at 37◦C for
1 h (Tabuchi et al., 2009). The sections were washed using TBS
(Tris-buffered saline) for three times and then scanned using a
Leica confocal laser scanning microscope.
TUNEL was also co-stained with NeuN (1:1000, Millipore),
Tuj1 (1:1000, SAB), and GFAP (1:500, Sigma–Aldrich).
Sections were incubated with Alexa Fluor 488 secondary
antibodies (Invitrogen, 1:500) or Cy3/Cy5 secondary
antibodies (Jackson ImmunoResearch; 1:500). Images were
captured using a ZEISS LSM 880 confocal laser scanning
microscope.
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Analysis of Dendritic Length
Dendrites for neurons in cortical layer V and hippocampal
CA1 were analyzed. Ctip2 antibody was used to label pyramidal
neurons in the above brain regions. Double immunostaining
on Ctip2/MAP2 was conducted using brain sections at 3 weeks
and 3 months. After the FIHC experiments, images doubly
positive for Ctip2/MAP2 were examined and observed under
the 20× objective lens of a ZEISS LSM 880 confocal laser
scanning microscope. By this way, we could identify Ctip2+
cells displaying long MAP2+ dendrites in cortical layer V. For
each mouse, we examined 2–3 brain sections to trace 10 cortical
Ctip2+ cells which sent long and unbroken MAP2+ dendrites
to cortical layer I/II. In hippocampal CA1, apical dendrites of
Ctip2+ cells were quite long and it was relatively easy to get
measured. Images were captured under the 10× objective lens
and then processed by ImageJ1 to measure dendritic length. For
each brain area, a total of 30 Ctip2+ neurons from three mice per
group were analyzed.
Morris Water Maze Test
The water maze is a circular pool (1.6 m in diameter). In the
hidden platform task, the platform (10 cm in diameter) was kept
under water and maintained in the same position. The mice were
trained to learn the hidden platform with four trials per day (the
inter trial interval, ITI = 15 min) for 5 days. Each training trial
lasted for 60 s (s). If the mice were unable to find the platform,
they were guided to it by hand and were allowed to stay on it for
30 s. The swimming path of the mice was monitored using the
ANY-Maze R© tracking system (ANY-Maze, Stoelting Co., Wood
Dale, IL, United States). After the last training trial of 24 h on day
5, the mice were subjected to a probe test in which the platform
was removed and the mice were allowed to search for it for 60 s.
Rotarod Test
The rotarod test was conducted in the same experimental room
for the open-field test. The mice were placed in a neutral position
on a stationary rotarod (3 cm in diameter, ShangHai Biowill Co.,
Ltd., Shanghai). Timers were used to record the time to fall. Mice
were tested on the rotarod at constant rotation speeds of 10, 20,
30, and 40 rpm/min.
Open-Field Test
The ANY-Maze R© system was used to monitor locomotion of the
mice. A 40 cm × 40 cm plexiglas chamber was set in a quiet
laboratory room. The area, 10 cm to the walls, was defined as the
wall area. During the test, the mouse was placed in the center of
the open-field chamber and allowed to move for 10 min. After
each testing trial, the chambers were thoroughly cleaned by 70%
ethanol to get rid of odors left by animals tested in a previous
trial. The total distance traveled and the time spent in different
areas were recorded.
Data Analysis
Data were presented as the mean± SEM. For behavioral data and
cell counting data, analysis of variance (ANOVA) was conducted
1https://imagej.nih.gov/ij/
to compare main genotype effects. For biochemical results, two-
tailed Student’s t-test was performed to examine the difference
between control and cKO mice; p < 0.05 (∗) and p < 0.01 (∗∗)
were considered statistically significant and highly significant,
respectively.
RESULTS
Reduced Size of the Cortex in PDK1 cKO
Mice
Early work has shown that PDK1−/− mice display multiple
abnormalities and die at embryonic day 9.5 (E9.5) (Lawlor et al.,
2002). In this study, we have generated viable forebrain-specific
PDK1 cKO (PDK1f /f ;Emx1-Cre) mice. These mutant animals
exhibited smaller cerebrum than controls did (Figure 1A).
To examine the inactivation pattern of PDK1 mediated by
Cre recombination, the mTmG mouse (Muzumdar et al.,
2007) was crossed to the Emxl-Cre mouse to obtain Emxl-
Cre;mTmG. In the latter, the expression of green fluorescence
protein (GFP) was mainly observed in the cortex and the
hippocampus (Figure 1B). To examine the inactivation efficiency
of PDK1, we performed Western blotting for PDK1 using cortical
homogenates. Significantly reduced PDK1 protein levels were
observed in the cortex of PDK1 cKO mice at 3 weeks and
3 months of age (Figure 1C). The residual amount of PDK1
was likely from cells including GABAergic neurons, blood cells,
glial cells, and a small proportion of excitatory neurons that
do not express the Cre recombinase. We further conducted
double-immunostaining for NeuN and PDK1. We found that the
majority of cortical NeuN positive (+) cells in PDK1 cKO mice
were PDK1 negative. In contrast, neurons in control mice were
doubly positive for NeuN/PDK1 (Figure 1D).
Nissl staining was used to examine brain morphology. There
was remarkable reduction on the size of the cortex in PDK1 cKO
mice (Figure 1E). The thickness of the cortex in PDK1 cKO
mice was decreased by about 50% as compared to age-matched
littermate controls (Figure 1Ea’–d’). Quantification data showed
that the cortical volume was dramatically decreased in PDK1 cKO
mice either at 3 weeks or 3 months (Figure 1F). In contrast, the
size of the cerebellum in PDK1 cKO mice was not decreased at
either age (Figure 1E), likely due to that Cre recombinase was
not expressed in cerebellar neurons. Moreover, the measurement
on the averaged area of the cerebellum per section showed
no significant difference between two genotypes at either age
(3 weeks: control= 100± 2.6%, cKO= 103.1± 2.3%; 3 months:
control = 100 ± 3.5%, cKO = 99.4 ± 3.7%; ps > 0.6, Student’s
t-test).
Loss of Mature Neurons in PDK1 cKO
Mice
We measured the number of mature neurons using NeuN as a
marker. First, IHC on NeuN revealed significant reductions in
the cortex size and the total number of NeuN+ cells in PDK1
cKO mice aged at 3 weeks and 3 months (Figure 2A). Consistent
with this, Western analysis confirmed reduced NeuN levels
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FIGURE 1 | Reduced size of the cortex in forebrain-specific PDK1 cKO mice. (A) Representative brain photos for a control mouse and a PDK1 cKO mouse at P0.
(B) The expression pattern of GFP in the brain of a 3-week-old Emx1-Cre;mTmG mouse. GFP was mainly expressed in the cortex (CTX) and the hippocampus (HIP)
but not the striatum (STR), the thalamus (THA), or the cerebellum. (C) Western analysis on PDK1. Cortical homogenates from mice aged at 3 weeks and 3 months
(n = 3–4/group/age) were prepared. There was significant difference on protein levels of PDK1 between control and PDK1 cKO mice (3 weeks: control = 100 ± 4.6%,
cKO = 58.0 ± 5.8%; 3 months: control = 100 ± 3.5%, cKO = 60.3 ± 2.1%; ps < 0.005). GAPDH served as the loading control. (D) Double-immunostaining for
NeuN/PDK1 in mice at 3 weeks of age. Most NeuN+ cells in control brain were PDK1+ but very few NeuN+ cells in PDK1 cKO brain were PDK1+. Scale
bar = 100 µm. (E) Nissl staining for mice at 3 weeks and 3 months. Boxed areas in control (a,c) and cKO (b,d) were enlarged as a’, c’, b’, and d’, respectively.
(F) Relative cortical volume. There was significant difference on the size of the cortex between control and PDK1 cKO mice at 3 weeks (control = 100 ± 9.9%,
cKO = 24.1 ± 2.0%; n = 3–4 mice/group; p < 0.001) or 3 months (control = 100 ± 4.4%, cKO = 14.9 ± 1.9%; n = 3–4 mice/group; p < 0.001).
(Figure 2B). Second, a stereological cell counting method was
used to count NeuN+ cell number (West and Gundersen, 1990;
Tabuchi et al., 2009; Chen et al., 2010). Our results showed that
the total number of NeuN+ cells was dramatically decreased in
PDK1 cKO mice (Figure 2C). The measurement on the diameter
for the cell body of NeuN+ cells indicated smaller size of neurons
in PDK1 cKO mice than in controls (Figure 2D). However, the
density of NeuN+ cells in PDK1 cKO mice was increased as
compared to control animals (Figure 2E). This finding was in
agreement with that reported on PDK1 conditional knock-in
mice (Cordon-Barris et al., 2016). Overall, conditional deletion
of PDK1 in the forebrain resulted in remarkable loss of mature
neurons.
To investigate whether neuron loss occurred via apoptosis,
we conducted the TUNEL assay (Tabuchi et al., 2009). Brain
sections of PDK1 cKO mice aged at P0, 1 week, and 3 weeks
were used. We found that the total number of TUNEL+ cells
in the cortex of PDK1 mutants was increased (Figure 2F and
Supplementary Figure 1). Cell counting results confirmed that
the averaged number of TUNEL+ cells per section in PDK1 cKO
mice was significantly larger than that in controls (Figure 2G:
F = 60, df1/8, p < 0.001 and Supplementary Figure 1),
suggesting enhanced apoptotic cell death. To identify which cell
type underwent apoptosis, we performed double-staining for
TUNEL/NeuN, TUNEL/Tuj1, or TUNEL/GFAP (Figure 2H).
Only TUNEL+/NeuN+ and TUNEL+/Tuj1+ cells (Figure 2H,
indicated by white arrows) were observed in PDK1 cKO mice as
compared to controls. No TUNEL+/GFAP+ cells were detected
(Figure 2H).
Unchanged Self-renewal of NPCs in
PDK1 cKO Mice
To determine the possibility that loss of cortical neurons was
caused by deficient self-renewal of NPCs, we first performed
BrdU pulse-labeling experiment, in which BrdU labels NPCs
at the S-phase of the cell cycle. No qualitative changes on
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FIGURE 2 | Remarkable loss of mature neurons in PDK1 cKO mice. (A) IHC for NeuN. There were significant reductions on NeuN+ cells in the cortex and the
hippocampus of PDK1 cKO mice at 3 weeks (a–d) and 3 months (e–h). Scale bar = 50 µm. (B) Western blotting on NeuN. There were significant differences on
NeuN protein levels between control and PDK1 cKO groups at 3 weeks and 3 months (ps < 0.01). β-actin served as the loading control. (C) Relative number of
NeuN+ cells was significantly different between control and PDK1 cKO mice at 3 weeks (control = 100 ± 9.8%, cKO = 39.8 ± 3.8%; n = 3–4/group; p < 0.005) or
3 months (control = 100 ± 0.8%, cKO = 22.0 ± 3.6%; n = 3–4/group; p < 0.001). (D) Relative diameter of NeuN+ cells was significantly decreased in PDK1 cKO
mice at 3 weeks (control = 100 ± 0.2%, n = 118 cells from 3 mice; cKO = 60.5 ± 0.1%, n = 345 cells from 3 mice; p < 0.001) or 3 months (control = 100 ± 0.2%,
n = 110 cells from 3 mice; cKO = 64.1 ± 0.2%, n = 365 cells from 3 mice; p < 0.001). (E) Cell density of NeuN+ neurons (per 1 mm3 area) was significantly
increased in PDK1 cKO mice at 3 weeks (control = 100 ± 3.9%, cKO = 146.3 ± 8.4%; n = 4 mice/group; p < 0.01) or 3 months (control = 100 ± 7.2%,
cKO = 155.5 ± 1.7%, n = 4 mice/group; p < 0.001). (F) TUNEL staining in the cortex of the mice aged at P0 (a,b), 1 week (c,d), and 3 weeks (e,f). Scale
bar = 50 µm. (G) The averaged number of TUNEL+ cells per section. There were significant increases in PDK1 cKO mice at P0 and 1 week but not 3 weeks
(∗p < 0.05; ∗∗p < 0.01). (H) Double-immunostaining for TUNEL/NeuN, TUNEL/Tuj1, or TUNEL/GFAP. Cells doubly positive for TUNEL(green)/NeuN(red) or
TUNEL(green)/Tuj1(red) were indicated by white arrows in PDK1 cKO mice. Cells doubly positive for TUNEL(green)/GFAP(red) were not found. Scale bar = 10 µm.
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BrdU immunoreactivity were detected in PDK1 cKO mice at
embryonic day 13.5 (E13.5), E15.5 or E17.5, as compared to
age-matched controls (Supplementary Figure 2A). Cell counting
results showed no significant reduction in the averaged number
of BrdU+ cells per 100 µm × 200 µm area of the VZ/SVZ (sub-
VZ) in PDK1 cKO embryos (Supplementary Figure 2B: p > 0.2
for each age).
We next conducted FIHC for PH3, a marker for NPCs at the
M-phase of the cell cycle. There was no qualitative difference in
the immunoreactivity of PH3 between control and PDK1 cKO
embryos (Supplementary Figure 2C). The averaged number of
PH3+ cells in the surface of the VZ for PDK1 cKO embryos was
not significantly decreased (Supplementary Figure 2D: p> 0.2 for
each age). Overall, the self-renewal or proliferation of NPCs was
not impaired in PDK1 cKO mice.
Loss of Synapses and Dendrites in PDK1
cKO Mice
To study whether the morphology of synapses and dendrites
was affected in PDK1 cKO mice, we first conducted FIHC
on synaptophysin (SVP38), a marker for pre-synaptic element.
Qualitatively reduced intensity of SVP38 immunoreactivity was
FIGURE 3 | Loss of synapses and dendrites in PDK1 cKO mice. (A) IHC for SVP38. Qualitatively altered immunoreactivity of SVP38 in the cortex and the
hippocampus in PDK1 cKO mice aged at 3 weeks (a–d) or 3 months (e–h). Scale bar = 100 µm. (B) Double-staining of MAP2/Ctip2 in the cortex (a,b) and the
hippocampus (c,d) of mice at 3 weeks. Dendrites, neurons, and cell bodies were labeled by MAP2 (green), Ctip2 (red), and DAPI (blue), respectively. Scale
bar = 100 µm. (C) There were significant differences on the averaged dendritic length for neurons in layer V of the cortex and in hippocampal CA1 area of control
and PDK1 cKO mice (30 Ctip2+ neurons from 3 mice per brain area per group; ∗∗p < 0.01). (D) Double-staining of MAP2/Ctip2 in mice at 3 months (a–d). Scale
bar = 100 µm. (E) The averaged length for dendrites was significantly different between two groups (30 Ctip2+ neurons from 3 mice per brain area per group;
∗∗p < 0.01).
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FIGURE 4 | Astroglial activation in PDK1 cKO mice. (A) IHC for GFAP. There was increased number of GFAP+ cells in the cortex of PDK1 cKO mice at 3 weeks or
3 months. Scale bar = 20 µm. (B) IHC for Iba1. There was no significant change on the total number of Iba1+ cells in the cortex of PDK1 cKO mice at 3 weeks or
3 months. Scale bar = 20 µm. (C) Double-immunostaining for GFAP/PDK1. Abundant PDK1+ neurons but few GFAP+ cells were seen in the cortex of control mice
(a,c,e). GFAP+ cells were PDK1 negative in PDK1 cKO mice (b,d,f). Scale bar = 25 µm.
observed in the cortex and the hippocampus of PDK1 cKO
mice across ages (Figure 3A), suggesting loss of synapses. In
addition, Western analyses on SVP38 and post-synaptic density
95 (PSD95) showed that their levels were significantly decreased
in PDK1 cKO mice (data not shown). We then performed
double-immunostaining of MAP2/Ctip2, markers for dendrites
and pyramidal neurons in cortical layer V, respectively. We found
that the immunoreactivity of MAP2 was qualitatively reduced
in the cortex of PDK1 cKO mice as compared to age-matched
littermate controls (Figures 3B,D), suggesting loss of dendrites.
We further measured the length of dendrites of Ctip2+ neurons.
The averaged dendritic length was significantly decreased in
PDK1 cKO mice either at 3 weeks (Figure 3C) or 3 months
(Figure 3E). For neurons in cortical layer V, there was more
than 80% of reduction on the averaged dendritic length in
PDK1 mutants. For pyramidal neurons in hippocampal CA1, the
averaged dendritic length was also dramatically reduced in PDK1
cKO mice (Figures 3C,E).
Astrocytosis in PDK1 cKO Mice
To study whether there were changes on glial cells in the
cortex of PDK1 cKO mice, first, IHC on GFAP was performed.
Increased number for GFAP+ cells was observed in the cortex
of PDK1 cKO mice. The increase in the immunoreactivity of
GFAP was subtle in PDK1 cKOs at 3 weeks (Figure 4Aa,b) but
more robust at 3 months (Figure 4Ac,d), suggesting progressive
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FIGURE 5 | Learning deficit in PDK1 cKO mice. (A) Escape latency for control and PDK1 cKO mice which were trained with a hidden platform task for 5 consecutive
days. There was significant difference on the latency to escape between the two genotype groups (n = 6/group). PDK1 cKO mice showed no improvement on their
performance during the 5-day training. (B) The length of swim-path. There was significant difference between control and PDK1 cKO mice across the training period.
(C) Quadrant occupancy in a probe test conducted 24 h after the last training trial. There was significant difference on the time spent in the target quadrant between
control and PDK1 cKO mice (∗p < 0.05). There was also significant difference in the average time spent in the remaining three quadrants (adjacent left, adjacent
right, and opposite) between control and PDK1 cKO animals (∗p < 0.05). (D) Latency to fall from a rotarod. Four different rotating speeds including 10, 20, 30, and
40 rpm/min were used. There was no significant difference on the latency to fall between control (n = 10) and PDK1 cKO mice (n = 6) at lower speeds (ps > 0.1).
There was significant difference between control and PDK1 cKO mice at the highest speed (∗∗∗∗p < 0.001).
astroglial activation. Second, IHC on Iba1 was conducted. The
immunoreactivity of Iba1 in control and PDK1 cKO mice did
not qualitatively differ at either age (Figure 4B), indicating no
significant microgliosis.
Since the Cre recombinase was also expressed in astrocytes in
PDK1f /f ;Cre mice, this suggested a possibility that loss of PDK1
may affect the cell number of astrocytes. We conducted double-
immunostaining for GFAP/PDK1. We found that GFAP+ cells
were largely PDK1 negative in PDK1 cKO mice (Figure 4C),
indicating that PDK1 was inactivated in astrocytes. Moreover,
it has been demonstrated that astrocytosis is associated with
neuron loss in neurodegenerative mouse models (Saura et al.,
2004; Tabuchi et al., 2009; Cheng et al., 2015). Overall, astroglial
activation in PDK1 cKO mice may be due to neuronal death and
a cell autonomous function of PDK1 in astrocytes.
Learning Deficit in PDK1 cKO Mice
To determine whether cognitive ability of PDK1 mutant mice was
affected, we used a Morris water maze task to test spatial learning.
In this task, 2- to 3-month-old mice were trained to learn a
hidden platform for 5 days. During the 5-day training period,
there was no improvement on the latency to escape in PDK1
cKO mice. ANOVA confirmed a highly significant main genotype
effect (F = 46.1, df = 1/10, p < 0.001) between two groups
of mice across 5 days (Figure 5A). There was also significant
genotype effect (F = 11.6, df = 3.0/30.1, p< 0.001) on the length
of swim-path (Figure 5B). Overall, these results indicated that
spatial learning was severely affected in PDK1 cKO mice.
One day after the last training trial, the mice were subjected
to a probe test, in which no platform was available in the
water. The average time spent in the target and other quadrants
of the water maze was analyzed (Figure 5C). Significant
genotype effect (F = 8.5, df = 1/10, p < 0.05) and significant
quadrant × genotype effect (F = 4.0, df = 2.4/23.9, p < 0.05,
Greenhouse-Geisser correction) were observed, suggesting that
no spatial memory had formed in PDK1 cKO mice. We also
found that the control mouse preferred to search for the target
quadrant but the PDK1 cKO swam randomly during the probe
test (data not shown).
Next, a rotarod task was conducted to examine motor
learning. A number of different rotating speeds including 10,
20, 30, and 40 rpms/min were used. The latency to fall from
the rotating rod was averaged (Figure 5D). ANOVA revealed
a significant speed × genotype effect (F = 22.8, df = 1.5/21.0,
p< 0.001). At lower speeds including 10, 20, or 30 rpm/min, there
were no significant genotype effects on the latency to fall between
control and PDK1 cKO mice (ps > 0.1). However, there was
significant genotype effect at the speed of 40 rpm/min (p< 0.001),
likely suggesting impairment on motor learning.
Decreased Activities for Akt and
mTORC1 in PDK1 cKO Mice
Our biochemical analysis showed that levels of total Akt
(T-Akt) were not changed in PDK1 cKO mice at either age
(Figure 6A, ps > 0.2), indicating unaltered Akt expression. In
contrast, relative levels of pAktThr308 were decreased in PDK1
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FIGURE 6 | Levels of pAkt and pGSK3 in PDK1 cKO mice. (A) Western analyses on pAkt and total Akt (T-Akt). There were significant differences on relative levels of
pAktT308 and pAktS473 between control and PDK1 cKO mice at 3 weeks and 3 months (∗∗p < 0.01; n = 3–4/group/age). There was no significant difference on
T-Akt levels between control and PDK1 cKO mice at either age (ps > 0.2). GAPDH served as the loading control. (B) Western analyses on pGSK3α, pGSK3β, total
GSK3α, and total GSK3β. There were significant differences on relative levels of pGSK3αS21 and pGSK3βS9 between control and PDK1 cKO mice at 3 weeks and
3 months (∗∗p < 0.01). There were no significant differences on levels of total GSK3α and GSK3β between control and PDK1 cKO mice (ps > 0.5). GAPDH served
as the loading control.
cKO mice (Figure 6A) (3 weeks: control = 100 ± 10.5%,
cKO = 37.0 ± 1.1%; 3 months: control = 100 ± 1.2%,
cKO = 35.5 ± 1.3%; n = 3–4/group/age; ps < 0.01).
In contrast, levels of pAktSer473 were increased in PDK1
cKO mice (Figure 6A, ps < 0.01). In agreement with this,
increased levels of pAktSer473 were reported in the brain
of PDK1f /f ;GFAP-Cre mice (Figure 4 in Chalhoub et al.,
2009).
The finding of reduced pAktThr308 levels suggested that Akt
activity might be decreased. As a major Akt substrate, GSK3
was then examined. Levels of total GSK3α and GSK3β did not
differ between two groups (Figure 6B), but those for pGSK3αSer21
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FIGURE 7 | Enhanced PKA activity but decreased mTORC1 activity in PDK1 cKO mice. (A) Western blotting for pAkt substrates. Several bands for Akt downstream
targets were decreased in PDK1 cKO mice (n = 3 mice/group). (B) Western blotting for pPKA substrates, pCREB and PKA Reg1α. Several PKA downstream targets
exhibited increased levels in PDK1 cKO mice. Levels for pCREBSer133 but not PKA Reg1α were increased (n = 3 mice/group). (C) Western blotting for pS6K and
pS6 in control and PDK1 cKO mice. (D) There were significant differences on relative levels of pS6K and pS6 between control and PDK1 cKO mice at 3 months
(n = 3 mice/group; ∗p < 0.05). There were no significant differences on levels of total S6K and S6 between control and PDK1 cKO mice (ps > 0.5). β-actin was used
as the loading control.
and pGSK3βSer9 were increased in PDK1 cKO mice either at
3 weeks (pGSK3α: control = 100 ± 6.3%, cKO = 244.8 ± 15.1%;
pGSK3β: control = 100 ± 11.2%, cKO = 187.3 ± 13.7%;
ps < 0.01) or 3 months (pGSK3α: control = 100 ± 1.6%,
cKO = 146.6 ± 5.3%; pGSK3β: control = 100 ± 8.0%,
cKO = 148.5 ± 7.4%; ps < 0.01; n = 3–4/group/age).
Due to negative correlation between pGSK3αSer21/3βSer9 levels
and GSK3 activity, this finding suggested that GSK3 was
inactivated. In agreement with this, increased pGSK3αSer21/3βSer9
was reported in PDK1f /f ;GFAP-Cre mice as well (Figure 4 in
Chalhoub et al., 2009).
It has been shown that GSK3 is phosphorylated by several
kinases including Akt (Cross et al., 1995) and PKA (Fang et al.,
2000; Li et al., 2000). First, Western analysis on pAkt substrates
was performed to examine overall Akt activity. Our results
showed that levels for several bands of Akt substrates were
reduced in PDK1 cKO mice as compared to controls (Figure 7A),
suggesting decreased activity. Second, Western analysis on
pPKA substrates was performed. A number of pPKA substrates
exhibited increased levels (Figure 7B), suggesting enhanced
activity. Consistent with this, relative levels for pCREBSer133, a
well-known PKA substrate, were increased in PDK1 cKO mice
(Figure 7B: control = 100 ± 5.8%; cKO = 387.1 ± 37.2%;
p < 0.01). In contrast, levels of PKA regulatory subunit 1α (PKA
Reg1α) were not changed (Figure 7B: control = 100 ± 1.2%;
cKO= 99.1± 7.2%; p> 0.9).
Previous evidence has demonstrated that the mTOR signaling
is critical for neuronal survival (Sarbassov et al., 2005; Kim
et al., 2010) and dendritic morphology (Jaworski et al., 2005;
Kumar et al., 2005). To investigate whether mTORC1 activity
was affected, we examined pS6K and pS6 using cortical
samples at 3 months. We found that levels for total S6K
and S6 were not changed in PDK1 cKO mice (Figures 7C,D,
ps > 0.5). However, those for pS6KThr389 and pS6Ser235/236 were
dramatically decreased (ps < 0.05). Overall, mTORC1 activity
was decreased in PDK1 cKO mice.
DISCUSSION
PDK1 is a key member in the PI3K signaling (Mora et al., 2004;
Engelman et al., 2006) and has been implicated in neurological
diseases (Liu et al., 2011; Pietri et al., 2013). Early embryonic
lethality of PDK1−/− mice excludes the possibility to study
whether loss of endogenous PDK1 affects neuronal survival
during cortical development. In this study, viable forebrain-
specific PDK1 cKO mice were generated. The following novel
findings were reported. First, conditional deletion of PDK1 in the
forebrain causes dramatic neuron loss and increased apoptotic
cell death. Second, conditional deletion of PDK1 in the forebrain
results in impaired mTOR activity.
Microcephaly has been observed in early work using PDK1
cKO line in which PDK1 is conditionally inactivated in neurons
and astrocytes of the whole brain (Chalhoub et al., 2009).
Given that PDK1 is specifically deleted in the forebrain of
PDK1f /f ;Emx1-Cre mice, our findings are somehow consistent
with those reported previously (Chalhoub et al., 2009; Itoh et al.,
2016). First, the current model differs from the line Chalhoub
et al. (2009), in that the phenotype in the cerebellum is not
the same. This is likely due to that the inactivation of PDK1
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does not occur in neurons of the cerebellum in our cKO line.
Second, unlike PDK1f /f ;GFAP-Cre (Chalhoub et al., 2009) or
PDK1f /f ;Emx1-Cre (this study), PDK1f /f ;Nestin-Cre mice die
shortly after birth (Itoh et al., 2016) and therefore cannot be
used for the study on postnatal brain. Third, PDK1f /f ;Nex-Cre
mice survive to adulthood and display cortical lamination defect
(Itoh et al., 2016). Moreover, it has been nicely demonstrated that
abnormal cortical lamination in PDK1f /f ;Nex-Cre mice is caused
by impairment on PDK1/Akt-dependent neuronal migration
(Itoh et al., 2016).
Since the total number of NeuN+ cells is dramatically
reduced and the length of dendrites is significantly decreased in
PDK1 cKO mice, these could directly lead to the formation of
small cortex. Overall, endogenous PDK1 may negatively regulate
apoptosis in the cortex and therefore control the brain/cortex
size. Interestingly, apoptosis is involved in cell death in brain
diseases displaying age-related neuron loss. First, previous studies
have shown that increased apoptosis is associated with neuron
loss in neurodegenerative mouse models (Feng et al., 2004;
Tabuchi et al., 2009; Wines-Samuelson et al., 2010; Cheng et al.,
2015). Second, early work has demonstrated increased apoptotic
cell death in the brain of AD (Su et al., 1994; Lassmann et al.,
1995; Anderson et al., 1996).
Since increased number of TUNEL+/NeuN+ or
TUNEL+/Tuj1+ cells was found in PDK1 cKO mice, it was
reasonable to conclude that neuronal apoptosis contributes to
cortical neuron loss. In contrast, neuron loss in PDK1 cKO mice
is unlikely due to proliferation of NPCs during development,
since our results showed that the self-renewal of NPCs was not
impaired as revealed by the BrdU pulse-labeling and PH3 IHC
experiments.
To explore the underlying molecular mechanisms, we focused
on the Akt/mTOR pathway. First of all, our biochemical results
on pAktThr308 and pAkt substrates have strongly suggested
that conditional inactivation of PDK1 leads to reduced Akt
activity. Second, our analyses on pS6K and pS6 indicated
decreased activity of mTORC1 in PDK1 cKO mice. Third,
PDK1f /f ;Emx1-Cre mice exhibit increased pGSK3 levels, which
may be caused by enhanced PKA activity. Consistent with
this notion, previous evidence has shown that PKA inhibits
GSK3 by phosphorylating the Ser21/Ser9 of GSK3α/3β (Fang
et al., 2000), and that the phosphorylation of GSK3 by PKA
does not require activation of Akt (Li et al., 2000). Overall,
since PDK1, Akt, or mTOR is important for cell/neuron
survival and dendritic morphogenesis (Datta et al., 1997;
Jaworski et al., 2005; Kumar et al., 2005; Sarbassov et al.,
2005; Kharebava et al., 2008; Kim et al., 2010), it is
reasonable to conclude that PDK1 may control neuronal survival
during cortical development via the activation of Akt/mTOR
signaling.
In this study, we report that PDK1 cKO mice display deficit
on spatial learning and memory. Since it has been demonstrated
that neuron loss and synaptic loss directly contribute to
cognitive impairments in neurodegenerative disease (Gomez-
Isla et al., 1997; Terry, 2000), we reason that learning deficit
in PDK1 cKO mice is likely caused by massive loss of neurons
and synapses in the cortex. However, since there was an
increase in open-field activity in PDK1 cKO mice, it cannot
be ruled out that increased anxiety may directly cause learning
impairment or exacerbate learning deficit in PDK1 mutant
mice.
AUTHOR CONTRIBUTIONS
CX, LY, JH, RJ, HW, CH, TL, QW, and XZ conducted
experiments. GC, YX, ZYY, and ZZY designed experiments. GC,
ZYY, CX, and LY analyzed the data. GC, TS-J, and RM wrote the
article.
FUNDING
This work was supported by grants from the National Basic
Research Program of Ministry of Science and Technology
of China (2014CB942804), the National Natural Science
Foundation of China (31271123, 81230026, and 81630028),
the National Key Research and Development Program of
China (2016YFC1300504), the Key Research and Development
Program of Nanjing Municipal Health Bureau (ZKX16031),
the Fundamental Research Funds for the Central Universities
(14380012 and 14380322), the Jiangsu Provincial Key Medical
Discipline (ZDXKA2016020), and Alzheimer’s Research in the
United Kingdom.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: https://www.frontiersin.org/articles/10.3389/fncel.
2017.00330/full#supplementary-material
REFERENCES
Alessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R. J.,
Reese, C. B., et al. (1997). Characterization of a 3-phosphoinositide-
dependent protein kinase which phosphorylates and activates protein
kinase B. Curr. Biol. 7, 261–269. doi: 10.1016/S0960-9822(06)
00122-9
Anderson, A. J., Su, J. H., and Cotman, C. W. (1996). DNA damage and
apoptosis in Alzheimer’s disease: colocalization with c- Jun immunoreactivity,
relationship to brain area, and effect of postmortem delay. J. Neurosci. 16,
1710–1719.
Calleja, V., Alcor, D., Laguerre, M., Park, J., Vojnovic, B., Hemmings, B. A.,
et al. (2007). Intramolecular and intermolecular interactions of protein kinase
B define its activation in vivo. PLOS Biol. 5:e95. doi: 10.1371/journal.pbio.
0050095
Chalhoub, N., Zhu, G., Zhu, X., and Baker, S. J. (2009). Cell type specificity of
PI3K signaling in Pdk1- and Pten-deficient brains. Genes Dev. 23, 1619–1624.
doi: 10.1101/gad.1799609
Chen, G., Zou, X., Watanabe, H., van Deursen, J. M., and Shen, J. (2010).
CREB binding protein is required for both short-term and long-term memory
formation. J. Neurosci. 30, 13066–13077. doi: 10.1523/JNEUROSCI.2378-10.
2010
Frontiers in Cellular Neuroscience | www.frontiersin.org 12 October 2017 | Volume 11 | Article 330
fncel-11-00330 October 17, 2017 Time: 13:9 # 13
Xu et al. PDK1 Controls Cortical Neuron Survival
Cheng, S., Hou, J., Zhang, C., Xu, C., Wang, L., Zou, X., et al. (2015). Minocycline
reduces neuroinflammation but does not ameliorate neuron loss in a mouse
model of neurodegeneration. Sci. Rep. 5:10535. doi: 10.1038/srep10535
Cordon-Barris, L., Pascual-Guiral, S., Yang, S., Gimenez-Llort, L., Lope-
Piedrafita, S., Niemeyer, C., et al. (2016). Mutation of the 3-phosphoinositide-
dependent protein kinase 1 (PDK1) substrate-docking site in the developing
brain causes microcephaly with abnormal brain morphogenesis independently
of Akt, leading to impaired cognition and disruptive behaviors. Mol. Cell. Biol.
36, 2967–2982. doi: 10.1128/MCB.00230-16
Cross, D. A., Alessi, D. R., Cohen, P., Andjelkovich, M., and Hemmings, B. A.
(1995). Inhibition of glycogen synthase kinase-3 by insulin mediated by protein
kinase B. Nature 378, 785–789. doi: 10.1038/378785a0
Dainichi, T., Hayden, M. S., Park, S.-G., Oh, H., Seeley, J. J., Grinberg-Bleyer, Y.,
et al. (2016). PDK1 is a regulator of epidermal differentiation that activates
and organizes asymmetric cell division. Cell Rep. 15, 1615–1623. doi: 10.1016/j.
celrep.2016.04.051
Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., et al. (1997). Akt
phosphorylation of BAD couples survival signals to the cell-intrinsic death
machinery. Cell 91, 231–241. doi: 10.1016/S0092-8674(00)80405-5
Engelman, J. A., Luo, J., and Cantley, L. C. (2006). The evolution of
phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat.
Rev. Genet. 7, 606–619. doi: 10.1038/nrg1879
Fang, X., Yu, S. X., Lu, Y., Bast, R. C., Woodgett, J. R., and Mills, G. B. (2000).
Phosphorylation and inactivation of glycogen synthase kinase 3 by protein
kinase A. Proc. Natl. Acad. Sci. U.S.A. 97, 11960–11965. doi: 10.1073/pnas.
220413597
Feng, Q., Di, R., Tao, F., Chang, Z., Lu, S., Fan, W., et al. (2010). PDK1
regulates vascular remodeling and promotes epithelial-mesenchymal transition
in cardiac development. Mol. Cell. Biol. 30, 3711–3721. doi: 10.1128/MCB.
00420-10
Feng, R., Wang, H., Wang, J., Shrom, D., Zeng, X., and Tsien, J. Z. (2004).
Forebrain degeneration and ventricle enlargement caused by double knockout
of Alzheimer’s presenilin-1 and presenilin-2. Proc. Natl. Acad. Sci. U.S.A. 101,
8162–8167. doi: 10.1073/pnas.0402733101
Gomez-Isla, T., Hollister, R., West, H., Mui, S., Growdon, J. H., Petersen, R. C.,
et al. (1997). Neuronal loss correlates with but exceeds neurofibrillary tangles in
Alzheimer’s disease. Ann. Neurol. 41, 17–24. doi: 10.1002/ana.410410106
Gorski, J. A., Talley, T., Qiu, M., Puelles, L., Rubenstein, J. L., and Jones, K. R.
(2002). Cortical excitatory neurons and glia, but not GABAergic neurons, are
produced in the Emx1-expressing lineage. J. Neurosci. 22, 6309–6314.
Itoh, Y., Higuchi, M., Oishi, K., Kishi, Y., Okazaki, T., Sakai, H., et al. (2016). PDK1-
Akt pathway regulates radial neuronal migration and microtubules in the
developing mouse neocortex. Proc. Natl. Acad. Sci. U.S.A. 113, E2955–E2964.
doi: 10.1073/pnas.1516321113
Jaworski, J., Spangler, S., Seeburg, D. P., Hoogenraad, C. C., and Sheng, M.
(2005). Control of dendritic arborization by the phosphoinositide-3’-kinase-
Akt-mammalian target of rapamycin pathway. J. Neurosci. 25, 11300–11312.
doi: 10.1523/JNEUROSCI.2270-05.2005
Kharebava, G., Makonchuk, D., Kalita, K. B., Zheng, J.-J., and Hetman, M.
(2008). Requirement of 3-phosphoinositide-dependent protein kinase-1 for
BDNF-mediated neuronal survival. J. Neurosci. 28, 11409–11420. doi: 10.1523/
JNEUROSCI.2135-08.2008
Kim, S., Lehtinen, M. K., Sessa, A., Zappaterra, M. W., Cho, S.-H., Gonzalez, D.,
et al. (2010). The apical complex couples cell fate and cell survival to cerebral
cortical development. Neuron 66, 69–84. doi: 10.1016/j.neuron.2010.03.019
Kumar, V., Zhang, M. X., Swank, M. W., Kunz, J., and Wu, G. Y. (2005). Regulation
of dendritic morphogenesis by Ras-PI3K-Akt mTOR and Ras-MAPK signaling
pathways. J. Neurosci. 25, 11288–11299. doi: 10.1523/JNEUROSCI.2284-05.
2005
Lassmann, H., Bancher, C., Breitschopf, H., Wegiel, J., Bobinski, M., Jellinger, K.,
et al. (1995). Cell death in Alzheimer’s disease evaluated by DNA fragmentation
in situ. Acta Neuropathol. 89, 35–41. doi: 10.1007/BF00294257
Lawlor, M. A., Mora, A., Ashby, P. R., Williams, M. R., Murray-Tait, V., Malone, L.,
et al. (2002). Essential role of PDK1 in regulating cell size and development in
mice. EMBO J. 21, 3728–3738. doi: 10.1093/emboj/cdf387
Li, M., Wang, X., Meintzer, M. K., Laessig, T., Birnbaum, M. J., and Heidenreich,
K. A. (2000). Cyclic AMP promotes neuronal survival by phosphorylation of
glycogen synthase kinase 3β. Mol. Cell. Biol. 20, 9356–9363. doi: 10.1128/MCB.
20.24.9356-9363.2000
Liu, Y., Liu, F., Grundke-Iqbal, I., Iqbal, K., and Gong, C. X. (2011). Deficient brain
insulin signalling pathway in Alzheimer’s disease and diabetes. J. Pathol. 225,
54–62. doi: 10.1002/path.2912
Mora, A., Komander, D., van Aalten, D. M., and Alessi, D. R. (2004). PDK1, the
master regulator of AGC kinase signal transduction. Semin. Cell Dev. Biol. 15,
161–170. doi: 10.1016/j.semcdb.2003.12.022
Muzumdar, M. D., Tasic, B., Miyamichi, K., Li, L., and Luo, L. (2007). A global
double-fluorescent Cre reporter mouse. Genesis 45, 593–605. doi: 10.1002/dvg.
20335
Pietri, M., Dakowski, C., Hannaoui, S., Alleaume-Butaux, A., Hernandez-Rapp, J.,
Ragagnin, A., et al. (2013). PDK1 decreases TACE-mediated alpha-secretase
activity and promotes disease progression in prion and Alzheimer’s diseases.
Nat. Med. 19, 1124–1131. doi: 10.1038/nm.3302
Sarbassov, D. D., Ali, S. M., and Sabatini, D. M. (2005). Growing roles for the mTOR
pathway. Curr. Opin. Cell Biol. 17, 596–603. doi: 10.1016/j.ceb.2005.09.009
Saura, C. A., Choi, S.-Y., Beglopoulos, V., Malkani, S., Zhang, D., Rao, B. S., et al.
(2004). Loss of presenilin function causes impairments of memory and synaptic
plasticity followed by age-dependent neurodegeneration. Neuron 42, 23–36.
doi: 10.1016/S0896-6273(04)00182-5
Steen, E., Terry, B. M., Rivera, E. J., Cannon, J. L., Neely, T. R.,
Tavares, R., et al. (2005). Impaired insulin and insulin-like growth
factor expression and signaling mechanisms in Alzheimer’s disease - is
this type 3 diabetes. J Alzheimers Dis. 7, 63–80. doi: 10.3233/JAD-2005-
7107
Su, J. H., Anderson, A. J., Cummings, B. J., and Cotman, C. W.
(1994). Immunohistochemical evidence for apoptosis in Alzheimer’s
disease. Neuroreport 5, 2529–2533. doi: 10.1097/00001756-199412000-
00031
Tabuchi, K., Chen, G., Südhof, T. C., and Shen, J. (2009). Conditional
forebrain inactivation of nicastrin causes progressive memory impairment
and age-related neurodegeneration. J. Neurosci. 29, 7290–7301. doi: 10.1523/
JNEUROSCI.1320-09.2009
Talbot, K., Wang, H. Y., Kazi, H., Han, L. Y., Bakshi, K. P., Stucky, A., et al.
(2012). Demonstrated brain insulin resistance in Alzheimer’s disease patients
is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.
J. Clin. Invest. 122, 1316–1338. doi: 10.1172/JCI59903
Terry, R. D. (2000). Cell death or synaptic loss in Alzheimer disease. J. Neuropathol.
Exp. Neurol. 59, 1118–1119. doi: 10.1093/jnen/59.12.1118
Watatani, K., Hirabayashi, Y., Itoh, Y., and Gotoh, Y. (2012). PDK1 regulates
the generation of oligodendrocyte precursor cells at an early stage of mouse
telencephalic development. Genes Cells 17, 326–335. doi: 10.1111/j.1365-2443.
2012.01591.x
West, M. J., and Gundersen, H. J. (1990). Unbiased stereological estimation of the
number of neurons in the human hippocampus. J. Comp. Neurol. 296, 1–22.
doi: 10.1002/cne.902960102
Wines-Samuelson, M., Schulte, E. C., Smith, M. J., Aoki, C., Liu, X., Kelleher,
R. J., et al. (2010). Characterization of age-dependent and progressive cortical
neuronal degeneration in presenilin conditional mutant mice. PLOS ONE
5:e10195. doi: 10.1371/journal.pone.0010195
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2017 Xu, Yu, Hou, Jackson, Wang, Huang, Liu, Wang, Zou, Morris,
Spires-Jones, Yang, Yin, Xu and Chen. This is an open-access article distributed
under the terms of the Creative Commons Attribution License (CC BY). The use,
distribution or reproduction in other forums is permitted, provided the original
author(s) or licensor are credited and that the original publication in this journal
is cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.
Frontiers in Cellular Neuroscience | www.frontiersin.org 13 October 2017 | Volume 11 | Article 330
